Capn4 is a Marker of Poor Clinical Outcomes and Promotes Nasopharyngeal Carcinoma Metastasis via Nuclear Factor-κB-Induced Matrix Metalloproteinase 2 Expression
- Type
- Retraction
- Notice date
- 8/5/2024 0:00
- Journal
- Cancer Science
- Publisher
- Wiley
- Notice DOI
- 10.1111/cas.16305
- Original paper DOI
- 10.1111/cas.12416
Reasons
- Concerns/Issues about Image
- Investigation by Journal/Publisher
- Investigation by Third Party
- Original Data and/or Images not Provided and/or not Available
- Unreliable Results and/or Conclusions